10x Genomics, Inc. Income Statement

Income Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 71.08M146.31M245.89M298.85M490.49M516.41M618.73M610.78M
Cost of Revenue 10.56M28.66M61.03M58.47M74.09M120.39M209.41M196.30M
Gross Profit 60.52M117.65M184.86M240.38M416.40M396.02M409.31M414.48M
Operating items
Research & Development 32.16M47.54M83.10M123.38M211.75M265.67M270.33M264.70M
Selling, General & Administrative 46.74M87.94M130.83M202.33M257.56M298.30M343.33M344.34M
Other Operating Expenses 92.94M1.50M448.82M-0.66M60.98M
Operating Expenses 78.90M228.42M215.43M774.52M468.65M563.97M674.64M609.04M
Operating Income -18.38M-110.76M-30.57M-534.14M-52.25M-167.94M-265.33M-194.56M
EBIT -18.38M-110.76M-30.57M-534.14M-52.25M-167.94M-265.33M-194.56M
Non-operating items
Interest & Investment Income 0.31M1.02M2.81M1.53M0.21M6.65M16.91M18.45M
Other Non Operating Income 0.14M-0.25M-0.19M-1.52M-0.80M-0.20M-0.31M-1.58M
Non Operating Income -0.37M-1.63M-0.46M1.34M-1.46M5.97M16.57M16.86M
Net income details
EBT -18.74M-112.40M-31.03M-534.48M-53.72M-161.97M-248.76M-177.70M
Tax Provisions 0.02M0.09M0.22M8.30M4.51M4.03M6.34M4.93M
Profit After Tax -18.76M-112.48M-31.25M-542.73M-58.22M-166.00M-255.10M-182.63M
Income from Continuing Operations -18.76M-112.48M-31.25M-542.78M-58.22M-166.00M-255.10M-182.63M
Consolidated Net Income -18.76M-112.48M-31.25M-542.78M-58.22M-166.00M-255.10M-182.63M
Income towards Parent Company -18.76M-112.48M-31.25M-542.78M-58.22M-166.00M-255.10M-182.63M
Net Income towards Common Stockholders -18.76M-112.48M-31.25M-542.78M-58.22M-166.00M-255.10M-182.63M
Additional items
EPS (Basic) -1.62-8.40-0.80-5.37-0.53-1.46-2.18-1.52
EPS (Weighted Average and Diluted) -0.80-5.37-0.53-1.46-2.18-1.52
Shares Outstanding (Weighted Average) 96.17M107.61M111.71M114.46M118.21M121.05M
Shares Outstanding (Diluted Average) 39.09M101.15M110.35M113.86M117.17M120.45M
EBITDA -18.78M-112.51M-31.26M-542.74M-58.15M-167.94M-265.33M-194.56M
Interest Expenses 0.81M2.41M3.08M1.68M0.87M0.48M0.03M0.00M